In today's episode we’ll discuss the approval of Oxlumo for primary hyperoxaluria type 1, and approval of Imcivree for chronic weight management. The FDA also issued 2 EUAs for combination treatments for COVID. Don't forget to like, share, and subscribe! Enjoy!